COVID-19: CRISIS MANAGEMENT IN LUNG CANCER SURGERY

Authors

  • Susana Lareiro Cirurgia Torácica, CHVN Gaia/Espinho, Portugal
  • Miguel Guerra Cirurgia Torácica, CHVN Gaia/Espinho, Portugal

DOI:

https://doi.org/10.48729/pjctvs.49

Downloads

Download data is not yet available.

References

Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol 2009; 10: 589–97.

Li JY, Duan XF, Wang LP, et al. Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer. J Immunol Res 2014; 2014: 286170.

Longbottom ER, Torrance HD, Owen HC, et al. Features of postoperative immune suppression are reversible with interferon gamma and independent of interleukin-6 pathways. Ann Surg 2016; 264: 370–77.

Sica A, Massarotti M. Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun 2017; 85: 117–25.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21(3): 335-337. https://doi.org/10.1016/S1470-2045(20)30096-6

COVID 19: Elective Case Triage Guidelines for Surgical Care

Downloads

Published

30-06-2020

How to Cite

1.
Lareiro S, Guerra M. COVID-19: CRISIS MANAGEMENT IN LUNG CANCER SURGERY. Rev Port Cir Cardiotorac Vasc [Internet]. 2020 Jun. 30 [cited 2024 Nov. 23];27(2):75. Available from: https://pjctvs.com/index.php/journal/article/view/49

Issue

Vol. 27 No. 2 (2020): April - June

Section

Editorial Comment

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)

1 2 3 > >>